Administration

Suzette Smiley-Jewell, PhD

  • Scientific Program Manager
  • Administrative Core
Dr. Suzette Smiley-Jewell coordinates the Center's research projects and scientific cores to meet Center milestones, organizes Center educational activities, and helps investigators with their papers and reports. She has a Ph.D. in Pharmacology and Toxicology and is a Board Certified Editor of the Life Sciences.

Co-Lead

Amy Brooks-Kayal, MD, FAAN, FANA, FAES

  • CounterACT Co-Director and Project 1 Co-Lead
  • Project 1
Dr. Amy Brooks-Kayal is a Professor and Chair of Neurology in the School of Veterinary Medicine. Her research focuses on cellular and molecular pathways in the development of epilepsy following brain injury, with particular emphasis on identifying new therapies for the prevention and treatment of both seizures and cognitive co-morbidities characteristic of acquired epilepsy.

Marco Gonzalez, PhD

  • Project 2 Co-Lead
  • Project 2
Dr. Marco Gonzalez is an Associate Professor of Neurology in the School of Medicine. He is interested in developing new therapies that stop or prevent recurrent seizure episodes in epilepsy. He studies cellular and molecular mechanisms underlying epileptogenesis, particularly calpain dysregulation.  

Danielle Harvey, PhD

  • Core C Co-Lead
  • Core C
Dr. Harvey is Professor in the Division of Biostatistics, Department of Public Health Sciences. Her research primarily focuses on the statistical analysis of neuroimaging data to identify markers of disease progression. Dr. Harvey assists CounterACT investigators with study design, data analysis, and preparation of presentations and manuscripts.

Brad A Hobson, PhD

  • Core B Co-Lead
  • Core B
Dr. Brad Hobson is a Research Project Scientist at the Center for Molecular and Genomic Imaging at UC Davis. His research with the CounterACT program focuses on investigating the long term neurological consequences of acute organophosphate (OP) intoxication using in vivo imaging.

Jill Silverman, PhD

  • Project 3 Co-Lead
  • Project 3
Dr. Jill Silverman is a Professor in the Department of Psychiatry and Behavioral Sciences, School of Medicine, and affiliated with the MIND Institute. She specializes in rodent cognitive behavioral assays using technology that is analogous to clinical assessment tools.

Jun Yang, PhD

  • Core A Co-Lead
  • Core A
Dr. Jun Yang is a Research Scientist in the Department of Entomology and Nematology. He is an experienced analytical chemist and expert in metabolomics. His work includes analytical and data analysis methodology and metabolomics and lipidomics platform development.

Consultant

Mark McCoy, PhD

  • Consultant
  • Core A
Dr. Mark McCoy is an Assistant Project Scientist in the Department of Physiology and Membrane Biology. He serves as a consultant for the immunoassay project for the CounterACT program using his expertise in immunoassay detection of chemical compounds in the environment and biological samples.

Vikrant Singh, PhD

  • Consultant
  • Core A
Dr. Singh obtained his PhD at the Institute of Technology, Bombay (India) in organic chemistry and is an expert on the development of novel synthetic methodologies for furans, cyclohexadienones, carbohydrates, estradiol adducts and quinolones.

Donald A Bruun, BS

  • Core B Consultant
  • Core B
Donald Bruun is an Academic Program Management Officer and Lab Manager in the Department of Molecular Biosciences. Donald has focused his research on investigating novel neuroprotectants following acute exposures to organophosphates. Among his many lab skills, he has expertise in histological analyses, microscopic image acquisition, and image analysis of the brain.